Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Clinical trial NCT05701436 · UNKNOWN

Trial details

NCT number: NCT05701436
Sponsor: Zhujiang Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Liver, Cancer of, Primary Resectable

Start date: 2022-09-01
Primary completion: 2026-01-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.